Edwards Lifesciences Launches Philanthropic Initiative to Impact Global Burden of Heart Valve Disease
April 28 2014 - 11:48AM
Marketwired
Edwards Lifesciences Launches Philanthropic Initiative to Impact
Global Burden of Heart Valve Disease
Goal of Supporting the Education, Screening and Treatment of One
Million Underserved People by 2020
IRVINE, CA--(Marketwired - Apr 28, 2014) - Edwards Lifesciences
Corporation (NYSE: EW), the global leader in the science of heart
valves and hemodynamic monitoring, announced today that it has
launched a significant, multi-year philanthropic initiative --
themed Every Heartbeat Matters -- with a goal that, by 2020, its
philanthropy will impact the global burden of heart valve disease
by supporting the education, screening and treatment of one million
underserved people.
As shared with non-profit partners in December, the company will
celebrate the 10th anniversary of The Edwards Lifesciences Fund
(The Fund) this year by launching a charitable initiative focused
on achieving one specific goal. Every Heartbeat Matters was
unveiled at an event on April 27 at the American Association for
Thoracic Surgery (AATS) Annual Meeting currently underway in
Toronto. Joining Edwards for the launch were top leaders from AATS,
American College of Cardiology, American Heart Association, Patient
Advocate Foundation, Society of Thoracic Surgeons and WomenHeart,
who expressed their engagement with Edwards' philanthropy to
achieve the initiative goal in front of attending clinicians and
non-profit partners.
"By focusing our philanthropy on a particular problem that we
know well -- the global burden of heart valve disease -- we hope to
drive a meaningful change for underserved patients," said Michael
A. Mussallem, Edwards Lifesciences' chairman and CEO. "Through
Every Heartbeat Matters, we want to inspire the most creative
non-profit minds to join us as we seek to address challenging
issues to help vulnerable patients on their path to
wellness."
"We estimate that more than 6 million people in the U.S. and
millions more around the world suffer from heart valve disease -- a
disease that is largely treatable when resources are available,"
said Pedro J. del Nido, AATS president-elect, at the launch event.
"Speaking for the AATS Council, we are excited to work with
Edwards' philanthropy to develop new innovative ideas to address an
issue that impacts so many of our patients."
The company plans to continue supporting other health- and
community-focused programs through The Fund, while committing at
least half of its charitable grants during the six-year period
ending in 2020 to Every Heartbeat Matters. In 2013, The Fund gifted
$5.5 million to hundreds of non-profit organizations around the
world and the company expects to continue growing its giving
consistent with its success. More information about Every Heartbeat
Matters can be found at www.EveryHeartbeatMatters.com.
About Edwards
Lifesciences and The Edwards Lifesciences Fund Edwards
Lifesciences is the global leader in the science of heart valves
and hemodynamic monitoring. Driven by a passion to help patients,
the company partners with clinicians to develop innovative
technologies in the areas of structural heart disease and critical
care monitoring, enabling them to save and enhance lives. In 2004,
the company established The Edwards Lifesciences Fund at the
Vanguard Charitable Endowment Program to support advancements in
knowledge and improvements in quality-of-life, focusing primarily
upon cardiovascular disease and the communities where its employees
live and work. The Fund's mission is fulfilled by making grants to
qualified charitable organizations. Additional information about
the company and its Fund can be found at www.edwards.com.
Edwards, Edwards Lifesciences the stylized E logo, and Every
Heartbeat Matters are trademarks of Edwards Lifesciences
Corporation. All other trademarks are the property of their
respective owners.
Media Contact: Amanda C. Fowler 949-250-5070 Investor Contact:
David K. Erickson 949-250-6826
Edwards Lifesciences (NYSE:EW)
Historical Stock Chart
From Mar 2024 to Apr 2024
Edwards Lifesciences (NYSE:EW)
Historical Stock Chart
From Apr 2023 to Apr 2024